BACKGROUND: To investigate adiponectin levels in an obese population with and without obstructive sleep apnea syndrome (OSAS) and the acute modifications in adiponectin after a whole-night control by auto continuous positive air pressure (CPAP). METHODS: 46 obese subjects [22 males, 24 females, age 55.1+/-11.4 yr, body mass index (BMI) 38.9+/-6.5 kg/m2]: 11 OSAS with apnea/hypopnea index (AHI) from 10/h to 30/h, 14 OSAS with AHI >30/h and 21 without OSAS. Thirty-seven normal weight healthy subjects (20 males, 17 females, age 31.3+/-9.5 yr, BMI 21.5+/-1.8 kg/m2). Serum adiponectin levels, biochemical parameters, anthropometric measurements, pulmonary function, pulse-oxymetry and polisomnography. RESULTS: The 3 groups of obese patients were comparable for gender, BMI, age, fat mass, fat free mass, hip and waist circumference, waist-to-hip ratio (WHR), systolic and diastolic blood pressure and glycometabolic parameters. Adiponectin levels were significantly reduced in obese patients compared to healthy normal weight subjects (8.1+/-3.5 vs 11.3+/-4.8 microg/ml p<0.001) In particular, adiponectin showed a trend to decrease according to the severity of OSAS. No differences in adiponectin levels were found after a whole-night control by Auto CPAP. CONCLUSIONS: OSAS is associated with reduced levels of adiponectin independently of insulin-resistance and BMI. These low adiponectin levels may contribute to the increased mortality seen in such patients.
BACKGROUND: To investigate adiponectin levels in an obese population with and without obstructive sleep apnea syndrome (OSAS) and the acute modifications in adiponectin after a whole-night control by auto continuous positive air pressure (CPAP). METHODS: 46 obese subjects [22 males, 24 females, age 55.1+/-11.4 yr, body mass index (BMI) 38.9+/-6.5 kg/m2]: 11 OSAS with apnea/hypopnea index (AHI) from 10/h to 30/h, 14 OSAS with AHI >30/h and 21 without OSAS. Thirty-seven normal weight healthy subjects (20 males, 17 females, age 31.3+/-9.5 yr, BMI 21.5+/-1.8 kg/m2). Serum adiponectin levels, biochemical parameters, anthropometric measurements, pulmonary function, pulse-oxymetry and polisomnography. RESULTS: The 3 groups of obesepatients were comparable for gender, BMI, age, fat mass, fat free mass, hip and waist circumference, waist-to-hip ratio (WHR), systolic and diastolic blood pressure and glycometabolic parameters. Adiponectin levels were significantly reduced in obesepatients compared to healthy normal weight subjects (8.1+/-3.5 vs 11.3+/-4.8 microg/ml p<0.001) In particular, adiponectin showed a trend to decrease according to the severity of OSAS. No differences in adiponectin levels were found after a whole-night control by Auto CPAP. CONCLUSIONS: OSAS is associated with reduced levels of adiponectin independently of insulin-resistance and BMI. These low adiponectin levels may contribute to the increased mortality seen in such patients.
Authors: P Lloberes; E Ballester; J M Montserrat; E Botifoll; A Ramirez; A Reolid; C Gistau; R Rodriguez-Roisin Journal: Am J Respir Crit Care Med Date: 1996-12 Impact factor: 21.405
Authors: Vsevolod Y Polotsky; Jianguo Li; Naresh M Punjabi; Arnon E Rubin; Philip L Smith; Alan R Schwartz; Christopher P O'Donnell Journal: J Physiol Date: 2003-07-23 Impact factor: 5.182
Authors: Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel Journal: Endocr Rev Date: 2008-10-29 Impact factor: 19.871
Authors: Manuel Sánchez-de-la-Torre; Olga Mediano; Antonia Barceló; Javier Piérola; Monica de la Peña; Cristina Esquinas; Angelina Miro; Joaquin Durán-Cantolla; Alvar G Agustí; Francisco Capote; Jose Maria Marin; Josep Maria Montserrat; Francisco García-Río; Ferran Barbé Journal: Sleep Breath Date: 2011-09-13 Impact factor: 2.816
Authors: Jamie C M Lam; Aimin Xu; Sidney Tam; Pek-Ian Khong; Tzy-Jyun Yao; David C L Lam; Agnes Y K Lai; Bing Lam; Karen S L Lam; S M Mary Journal: Sleep Date: 2008-12 Impact factor: 5.849